Jean-Christophe Goffard

8PUBLICATIONS
154CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Immunogenetics (incl. genetic immunology)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 01, 2024
Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases.

Jérémie Rosain, Tom Le Voyer, Xian Liu

|Feb 14, 2023
Dynamics of Weight Change After Initiation of Contemporaneous Antiretroviral Therapy in Treatment-Naive HIV-1 Infected Patients: Results From the Belgian HIV Cohort 2015-2021.

Jens T Van Praet, Ben Serrien, Nathalie Ausselet

|Nov 07, 2022
Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination.

Aurélien Sokal, Paul Bastard, Pascal Chappert

|Jun 18, 2020
Early postmortem brain MRI findings in COVID-19 non-survivors.

Tim Coolen, Valentina Lolli, Niloufar Sadeghi

|Jul 24, 2018
2018 Belgian guidelines for the screening for latent tuberculosis in HIV-infected patients.

Chloé Wyndham-Thomas, Violette Dirix, Jean-Christophe Goffard

|May 03, 2018
Long-term treatment with atazanavir (ATV) in real life in Belgium: a retrospective observational cohort of 2264 HIV patients.

Stéphane De Wit, Eric Florence, Linos Vandekerkhove

Pageof 2